Brian Geldziler Email & Phone Number

Brian Geldziler, based in New York, New York, United States, is currently a Director, Head of Medical Writing - Oncology and Informed Consent and Global Clinical Trial Operations at Merck, bringing experience from previous roles at Otsuka Pharmaceutical Companies (u.s.), Imclone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company, Imclone Systems a Wholly Owned Subsidiary of Eli Lilly & Co and Novo Nordisk. Brian Geldziler holds a 2020 - 2022 Master of Science @ Columbia University School of Professional Studies. With a robust skill set that includes eCTD, Hematology, Pharmacovigilance, Medical Writing, Diabetes and more, Brian Geldziler contributes valuable insights to the industry. Brian Geldziler has 2 emails on RocketReach.